() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: SOL Global Investments Corp

SOL Global Adds California to Its MSO Portfolio with Proposed Acquisition of Premiere Cultivation, Processing, and Dispensary Companies

May 16, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) is pleased to announce that it has entered into letters of intent to acquire ECD, Inc., which operates as Northern Emeralds ("Northern Emeralds"), an industry leading cannabis cultivation, processing and distribution company headquartered in Humboldt County, California, as well as six (6) licensed dispensary companies in California that will subsequently operate under the nationally recognized "One Plant" brand.
Read more

SOL Global Signs Binding Agreement with Merida Capital Partners’ Subsidiary to Acquire Michigan Fully Licensed Cannabis Business

April 24, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB), the owner of 3 Boys Farms, LLC ("3 Boys"), which holds one of Florida's original 14 operating and vertically integrated medical marijuana treatment center licenses, is pleased to announce that it has entered into a binding letter of intent ("LOI") with cannabis-focused private equity firm Merida Capital Partners ("Merida") dated April 23, 2019 to acquire Merida's Michigan subsidiary, MCP Wellness, Inc.
Read more

SOL Global Completes Acquisition of 3 Boys Farms through the Purchase of CannCure Investments Inc

April 8, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) is pleased to announce the completion of its acquisition of CannCure Investments Inc. ("CannCure"), a privately-held Ontario corporation that indirectly holds 100% of 3 Boys Farms, LLC ("3 Boys Farms"), a Florida limited liability company with a Florida state license to cultivate, process and dispense medical marijuana.    
Read more

SOL Global to Spin Off Cannabinoid Drug Therapy Research and Development Subsidiary

April 5, 2019 /CNW/ - SOL Global Investments Corp. ("SOL" or the "Company") (CSE:SOL) (Frankfurt:9SB) (OTCQB:SOLCF)  is pleased to announce that it intends to spin off its wholly-owned subsidiary, Scythian Biosciences Inc. ("SBI"), into an independent, publicly-traded company (the "Spin-off"). Upon closing of the Spin-off, which is expected to occur on or before September 30, 2019, SOL shareholders will own shares of both companies.
Read more
Get $50 in free trades.